Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bolus vs Continuous Remimazolam for Anesthesia Induction
NCT05536323Unknown
- Sponsor
- Kangbuk Samsung Hospital
- Start
- Jul 2023
- Primary completion
- Nov 2023
- Modality
- Small Molecules
01
Overview
Randomised trial of remimazolam in general anesthesia (2 arms), sponsored by Kangbuk Samsung Hospital. Primary endpoint: Incidence of hypotension. Status: unknown.
02
Drugs
remimazolam
03
Conditions
general anesthesia
Beyond the preview
Go deeper on NCT05536323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05536323.